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Bidirectional association between 
gallstones and renal stones: two 
longitudinal follow-up studies using 
a national sample cohort
so Young Kim1, Chang Myeon song2, Hyun Lim3, Man sup Lim4, Woojin Bang5 & 
Hyo Geun Choi  6
the present study evaluated the associations between gallstones and renal stones using a national 
sample cohort of the Korean population. the Korean National Health Insurance service-National 
Sample Cohort was collected from 2002 to 2013. We designed two different longitudinal follow-up 
studies. In study I, we extracted gallstone patients (n = 20,711) and 1:4-matched control I subjects 
(n = 82,844) and analyzed the occurrence of renal stones. In study II, we extracted renal stone patients 
(n = 23,615) and 1:4-matched control II subjects (n = 94,460) and analyzed the occurrence of gallstones. 
Matching was performed for age, sex, income, region of residence, and history of hypertension, 
diabetes mellitus, and dyslipidemia. Crude and adjusted hazard ratios (HRs) were calculated using a Cox 
proportional hazards model, and the 95% confidence intervals (CIs) were calculated. Subgroup analyses 
were performed according to age and sex. The adjusted HR of renal stones was 1.93 (95% CI = 1.75–
2.14) in the gallstone group (P < 0.001). The adjusted HR of gallstones was 1.97 (95% CI = 1.81–2.15) 
in the renal stone group (p < 0.001). The results were consistent in all subgroup analyses. Gallstones 
increased the risk of renal stones, and renal stones increased the risk of gallstones.
A gallstone is a crystalline deposit in the gallbladder1. The prevalence of gallstones is 5.5% in men and 8.6% in 
women in the USA2 and 4.2–5.3% in Korea3,4. Gallstones are categorized as cholesterol stones, pigment stones, or 
mixed stones based on their composition1. Their prevalence rates in Korea are 58.1% for cholesterol stones, 25.2% 
for black pigment stones, and 12.1% for brown pigment stones5. Age, female sex, ethnicity, estrogen treatment, 
obesity, Western diet, low physical activity, liver cirrhosis, diabetes mellitus, and dyslipidemia are known risk 
factors for gallstones6.
A renal stone is a stone in the kidney or lower urinary tract. The prevalence of renal stones is 10.6% in men 
and 7.1% women in the USA7 and 5.0% in Korea8. The annual incidence is estimated to be 457 per 100,000 people 
in Korea9. The exact pathophysiology of renal stone formation is unclear. Various risk factors have been pro-
posed and include chronic kidney disease, poor hydration, abnormalities in calcium metabolism including hyper-
parathyroidism, increasing age, obesity, diabetes mellitus, warm climate, and high animal protein intake10–13. 
Approximately 80% of kidney stones are composed of calcium substrates. Renal stones are composed of calcium 
oxalate (56–61%), calcium phosphate (8–18%), uric acid (9–17%), struvite, or cysteine13.
The association between gallstones and renal stones has been reported in several studies14–16. However, the 
direction of the effect cannot be sufficiently evaluated in a cross-sectional study16. Only a single direction of the 
effect was evaluated in a cohort study14. Several studies have evaluated the effect using a bidirectional approach15. 
The purpose of this study is to bidirectionally evaluate the association between gallstones and renal stones using 
a national sample cohort of the Korean population. We designed two different longitudinal follow-up studies. In 
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one study, we extracted gallstone patients and 1:4-matched control subjects and analyzed the occurrence of renal 
stones. In the other study, we extracted renal stone patients and 1:4-matched control subjects and analyzed the 
occurrence of gallstones.
Results
study I. The mean follow-up periods were 65.74 (standard deviation, SD = 41.60) months and 64.87 
(SD = 41.80) months for the gallstone group and the control I group, respectively. The rate of renal stones was 
higher in the gallstone group (2.7% [563/20,711]) than in the control I group (1.4% [1,180/82,844], P < 0.001, 
Table 1). The general characteristics (age, sex, income, region of residence, and hypertension, diabetes, and dys-
lipidemia histories) of participants were exactly the same due to the matching (P = 1.000).
The crude and adjusted HRs of renal stones were 1.93 (95% CI = 1.75–2.14) and 1.93 (95% CI = 1.75–2.14) 
in the gallstone group, respectively (each P < 0.001, Table 2). In subgroup analyses, all crude and adjusted HRs 
of renal stones were higher in the gallstone group (each P < 0.05, Table 3). The adjusted HRs were 2.23 (95% 
CI = 1.10–4.50) in men <30 years old; 2.68 (1.20–5.96) in women <30 years old; 1.90 (95% CI = 1.62–2.23) in 
men 30–59 years old; 2.31 (95% CI = 1.89–2.82) in women 30–59 years old; 1.62 (95% CI = 1.27–2.06) in men 
≥60 years old; and 1.78 (95% CI = 1.36–2.33) in women ≥60 years old.
study II. The mean follow-up periods were 72.25 (SD = 41.52) months and 71.31 (SD = 41.75) months for 
the renal stone group and the control II group, respectively. The rate of gallstones was higher in the renal stone 
group (3.4% [793/23,615]) than in the control II group (1.7% [1,631/94,460], P < 0.001, Table 1). The general 
characteristics (age, sex, income, region of residence, and hypertension, diabetes, and dyslipidemia histories) of 
participants were exactly the same due to the matching (P = 1.000).
The crude and adjusted HRs of gallstones were 1.97 (95% CI = 1.81–2.14) and 1.97 (95% CI = 1.81–2.15) in 
the renal stone group, respectively (each P < 0.001, Table 4). In the subgroup analyses, all crude and adjusted 
HRs of gallstones were higher in the renal stone group (each P < 0.05, Table 5). The adjusted HRs were 1.78 (95% 
CI = 1.05–3.02) in men <30 years old; 3.27 (95% CI = 1.72–6.20) in women <30 years old; 1.85 (95% CI = 1.62–
2.11) in men 30–59 years old; 2.43 (95% CI = 2.03–2.91) in women 30–59 years old; 1.63 (95% CI = 1.32–2.00) in 
men ≥60 years old; and 2.15 (95% CI = 1.71–2.69) in women ≥60 years old.
Discussion
This study revealed a bidirectional association between gallstones and renal stones. Gallstones increased the risk 
of renal stones, and renal stones increased the risk of gallstones. In both studies, these relationships were consist-
ent in all subgroups according to age and sex.
The results of this study are similar to those of previous studies. Previous cohort studies have reported an 
increased HR of renal stones in gallstone patients as follows: 1.68 (95% = 1.59–1.77) in the general population14 
and 1.26 (95% CI = 1.09–1.44) in older women, 1.32 (95% CI = 1.14–1.52) in young women, and 1.28 (95% 
CI 1.03–1.57) in men15. The HR was 1.93 (95% CI = 1.75–2.14) in study I. The HR of gallstones in renal stone 
patients has been reported as follows: 1.17 (95% CI = 1.06–1.29) in older women, 1.31 (95% CI = 1.19–1.45) 
in young women, and 1.51 (95% CI = 1.35–1.68) in men15. The HR was 1.95 (95% CI = 1.18–2.15) in study II. 
In a cross-sectional design study, the odds ratio (OR) between renal stones and gallstones has been reported 
as follows: 1.65 (95% CI = 1.46–1.86) in older women, 1.85 (95% CI = 1.65–2.07) in young women, 1.61 (95% 
CI = 1.41–1.85) in men15 and 1.46 (95% CI = 1.24–1.73) in white individuals, and 3.01 (1.86–4.88) in African 
Americans16.
The association between gallstones and renal stones could be explained by common pathophysiology. First, 
obesity and metabolic syndrome are risk factors for both gallstones and renal stones17,18. Hyperinsulinemia 
may increase hepatic cholesterol secretion and cholesterol supersaturation by activating hydroxymethylglutaryl 
coenzyme A reductase or by upregulating hepatocyte LDL receptors19,20. Obesity and insulin resistance result in 
defective ammoniagenesis21, so diabetes can increase the risk of uric acid renal stones due to a low urinary pH22. 
Second, obesity is an independent risk factor for infection23. Infection of the gallbladder can result in liver cell 
damage and bile acid excretion24. Hemolysis and chronic bacterial infections can produce pigment stones in the 
gallbladder25. Obesity can increase the risk of urinary tract infections26. Third, intestinal malabsorption can result 
in decreased bile acid resorption and increased urinary oxalate27. Finally, water and ion channels in the gallblad-
der might affect urine composition28.
The advantages of this study are consistent with those of our previous studies using the national sample 
cohort29–31. We used a large, representative, nationwide population. Because National Health Insurance Service 
(NHIS) data include all citizens in the nation without exception, no participants were missing during the 
follow-up periods. The control groups were randomly selected by matching for age, sex, income, region of resi-
dence, and past medical histories to avoid confounding effects. Furthermore, an adjusted hazard model was used 
to minimize the confounders. We designed two different studies to analyze the direction of the effect.
This study has the several limitations. Despite the cohort study design, we could not exclude the effects of 
possible confounders that might affect both gallstones and renal stones. Because we did not have data for body 
mass index or smoking or alcohol history, we could not adjust for these factors. These lifestyle factors could 
influence or mediate the association between gallstones and renal stones. Patients who could not consult with a 
clinic might have been missed. The possibility of detection bias exists. Visits for one disease could increase the 
detection rates of the other disease. Therefore, we performed an additional analysis confined to >6 months after 
the detection of one disease (Supplementary Table S1). In study I, we analyzed the occurrence of renal stones >6 
months after detection of a gallstone. The adjusted HR was 1.43 (95% CI = 1.27–1.61, P < 0.001). In study II, we 
analyzed the occurrence of gallstones >6 months after detection of a renal stone. The adjusted HR was 1.53 (95% 
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Characteristics
Study I Study II
Gallstone 
(n, %)
Control I 
(n, %) P-value
Renal stone 
(n, %)
Control II 
(n, %) P-value
Age (years old) 1.000 1.000
   0–4 15 (0.1) 60 (0.1) 15 (0.1) 60 (0.1)
   5–9 9 (0.0) 36 (0.0) 29 (0.1) 116 (0.1)
   10–14 29 (0.1) 116 (0.1) 91 (0.4) 364 (0.4)
   15–19 171 (0.8) 684 (0.8) 443 (1.9) 1,772 (1.9)
   20–24 292 (1.4) 1,168 (1.4) 845 (3.6) 3,380 (3.6)
   25–29 684 (3.3) 2,736 (3.3) 1,595 (6.8) 6,380 (6.8)
   30–34 1,164 (5.6) 4,656 (5.6) 2,307 (9.8) 9,228 (9.8)
   35–39 1,505 (7.3) 6,020 (7.3) 2,740 (11.6) 10,960 (11.6)
   40–44 1,867 (9.0) 7,468 (9.0) 2,947 (12.5) 11,788 (12.5)
   45–49 2,073 (10.0) 8,292 (10.0) 3,068 (13.0) 12,272 (13.0)
   50–54 2,341 (11.3) 9,364 (11.3) 2,809 (11.9) 11,236 (11.9)
   55–59 2,160 (10.4) 8,640 (10.4) 2,279 (9.7) 9,116 (9.7)
   60–64 2,197 (10.6) 8,788 (10.6) 1,826 (7.7) 7,304 (7.7)
   65–69 1,988 (9.6) 7,952 (9.6) 1,304 (5.5) 5,216 (5.5)
   70–74 1,798 (8.7) 7,192 (8.7) 766 (3.2) 3,064 (3.2)
   75–79 1,262 (6.1) 5,048 (6.1) 360 (1.5) 1,440 (1.5)
   80–84 755 (3.6) 3,020 (3.6) 145 (0.6) 580 (0.6)
   85+ 401 (1.9) 1,604 (1.9) 46 (0.2) 184 (0.2)
Sex 1.000 1.000
   Male 10,027 (48.4) 40,108 (48.4) 15,260 (64.6) 61,040 (64.6)
   Female 10,684 (51.6) 42,736 (51.6) 8,355 (35.4) 33,420 (35.4)
Income 1.000 1.000
   1 (lowest) 634 (3.1) 2,536 (3.1) 284 (1.2) 1,136 (1.2)
   2 1,468 (7.1) 5,872 (7.1) 1,386 (5.9) 5,544 (5.9)
   3 1,200 (5.8) 4,800 (5.8) 1,484 (6.3) 5,936 (6.3)
   4 1,254 (6.1) 5,016 (6.1) 1,646 (7.0) 6,584 (7.0)
   5 1,466 (7.1) 5,864 (7.1) 1,697 (7.2) 6,788 (7.2)
   6 1,623 (7.8) 6,492 (7.8) 1,993 (8.4) 7,972 (8.4)
   7 1,835 (8.9) 7,340 (8.9) 2,384 (10.1) 9,536 (10.1)
   8 2,147 (10.4) 8,588 (10.4) 2,649 (11.2) 10,596 (11.2)
   9 2,486 (12.0) 9,944 (12.0) 2,992 (12.7) 11,968 (12.7)
   10 2,956 (14.3) 11,824 (14.3) 3,341 (14.1) 13,364 (14.1)
   11 (highest) 3,642 (17.6) 14,568 (17.6) 3,759 (15.9) 15,036 (15.9)
Region of 
residence 1.000 1.000
   Urban 9,290 (44.9) 37,160 (44.9) 11,149 (47.2) 44,596 (47.2)
   Rural 11,421 (55.1) 45,684 (55.1) 12,466 (52.8) 49,864 (52.8)
Hypertension 1.000 1.000
   Yes 9,008 (43.5) 36,032 (43.5) 8,367 (35.4) 33,468 (35.4)
   No 11,703 (56.5) 46,812 (56.5) 15,248 (64.6) 60,992 (64.6)
Diabetes Mellitus 1.000 1.000
   Yes 5,366 (25.9) 21,464 (25.9) 4,509 (19.1) 18,036 (19.1)
   No 15,345 (74.1) 61,380 (74.1) 19,106 (80.9) 76,424 (80.9)
Dyslipidemia 1.000 1.000
   Yes 6,620 (32.0) 26,480 (32.0) 6,850 (29.0) 27,400 (29.0)
   No 14,091 (68.0) 56,364 (68.0) 16,765 (71.0) 67,060 (71.0)
Renal stone <0.001*
   Yes 563 (2.7) 1,180 (1.4) N/A N/A
   No 20,148 (97.3) 81,664 (98.6) N/A N/A
Gallstone <0.001*
   Yes N/A N/A 793 (3.4) 1,631 (1.7)
   No N/A N/A 22,822 (96.6) 92,829 (98.3)
Table 1. General Characteristics of Participants. *Chi-square test, significance at P < 0.05.
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CI = 1.39–1.69, P < 0.001). Therefore, the association between gallstones and renal stones was consistent, even 
considering the possibility of detection bias.
In conclusion, gallstones increased the risk of renal stones, and renal stones increased the risk of gallstones.
Materials and Methods
study population and Data Collection. This study was approved by the ethics committee of Hallym 
University (2014-I148). The ethics committee of Hallym University waived the written informed consent from 
the study participants. All analyses adhered to the guidelines and regulations of the ethics committee of Hallym 
University.
This national cohort study used data of the Korean Health Insurance Review and Assessment Service-National 
Sample Cohort (HIRA-NSC). The sample cohort was directly extracted from the mother population from the 
Korean NHIS to minimize non-sampling errors. The sample cohort consisted of approximately 2% of the entire 
Korean population (50 million). The sampling was performed based on the 1,476 levels (age [18 categories], sex 
[2 categories], and income level [41 categories]) using randomized stratified systematic sampling methods via 
proportional allocation to represent the entire population. After data selection, a statistician verified the appropri-
ateness of the sample by comparing the data from the entire Korean population to the sample data. The National 
Health Insurance Sharing Service provided the details of the sampling procedures on their website32. This cohort 
Characteristics
Renal stone
Crude P-value Adjusted† P-value
Gallstone 1.93 (1.75–2.14) <0.001* 1.93 (1.75–2.14) <0.001*
Control 1.00 1.00
Table 2. Crude and adjusted hazard ratios (95% confidence intervals) of gallstone for renal stone in study I. 
*Cox proportional hazard regression model, significance at P < 0.05. †Adjusted model for age, sex, income, 
region of residence, hypertension, diabetes, and dyslipidemia.
Characteristics
Renal stone
Crude P-value Adjusted† P-value
Age <30 years old, men (n = 2,395)
  Gallstone 2.22 (1.10–4.48) 0.027* 2.23 (1.10–4.50) 0.026*
  Control 1.00 1.00
Age <30 years old, women (n = 3,605)
  Gallstone 2.68 (1.20–5.96) 0.016* 2.68 (1.20–5.96) 0.016*
  Control 1.00 1.00
Age ≥30 and <60 years old, men (n = 27,720)
  Gallstone 1.90 (1.62–2.22) <0.001* 1.90 (1.62–2.23) <0.001*
  Control 1.00 1.00
Age ≥30 and <60 years old, women (n = 27,830)
  Gallstone 2.30 (1.89–2.81) <0.001* 2.31 (1.89–2.82) <0.001*
  Control 1.00 1.00
Age ≥60 years old, men (n = 20,020)
  Gallstone 1.62 (1.27–2.06) <0.001* 1.62 (1.27–2.06) <0.001*
  Control 1.00 1.00
Age ≥60 years old, women (n = 21,985)
  Gallstone 1.78 (1.36–2.34) <0.001* 1.78 (1.36–2.33) <0.001*
  Control 1.00 1.00
Table 3. Subgroup analysis of crude and adjusted hazard ratios (95% confidence intervals) of gallstone for renal 
stone according to age and sex in study I. *Cox proportional hazard regression model, significance at P < 0.05. 
†Adjusted model for age, sex, income, region of residence, hypertension, diabetes, and dyslipidemia.
Characteristics
Gallstone
Crude P-value Adjusted† P-value
Renal stone 1.97 (1.81–2.14) <0.001* 1.97 (1.81–2.15) <0.001*
Control 1.00 1.00
Table 4. Crude and adjusted hazard ratios (95% confidence intervals) of renal stone for gallstone in study II. 
*Cox proportional hazard regression model, significance at P < 0.05. †Adjusted model for age, sex, income, 
region of residence, hypertension, diabetes, and dyslipidemia.
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database is composed of (i) personal information, (ii) health insurance claim codes (procedures and prescrip-
tions), (iii) diagnostic codes using the International Classification of Disease-10 (ICD-10), (iv) death records from 
the Korean National Statistical Office (using the Korean Standard Classification of disease), (v) socio-economic 
data (residence and income), and (vi) medical examination data for each participant over 2002 to 2013.
The exact population statistics were available using the NHIS database because all Korean citizens are identi-
fied by a 13-digit resident registration number from birth to death. All Koreans have to enroll in the NHIS. All the 
medical records of all Korean hospitals and clinics are registered using the 13-digit resident registration number 
to register individual patients in the medical insurance system. Thus, the risk of duplicated medical records is 
minimal, even if a patient visits different hospitals or clinics. In addition, all medical treatments in Korea can be 
traced without exclusion using the HIRA system. In Korea, reporting notice of death to an administrative entity 
is legally obligatory before a funeral can be held, and the reason of death and date are documented by medical 
doctors on a death certificate.
participant selection. Of 1,125,691 patients with 114,369,638 medical claim codes, the participants who 
were diagnosed with gallstones (ICD-10: K80; Cholelithiasis) were included. Among them, the participants who 
visited hospitals or clinics ≥2 times for gallstones (n = 21,501) were selected. Histories of renal stones were clas-
sified using ICD-10 codes (N20; Calculus of kidney and ureter). We selected participants who visited hospitals or 
clinics ≥2 times for renal stones (n = 24,123).
We designed study I and II. These studies are independent from each other. For study I, the patients with gall-
stone were followed up for the presence of renal stone (Fig. 1a). Thus, gallstone was the first stone event, followed 
by renal stone. In contrast, study II investigated the subsequent occurrence of gallstone after renal stone (Fig. 1b). 
In these cases, the renal stone was the first stone event, followed by gallstone.
Study I. The 1:4 matching was performed between the gallstone patients and the control I group who were never 
diagnosed with gallstones from 2002 through 2013. The control group was selected from the total population 
(n = 1,104,190). The age, group, sex, income group, region of residence, and past medical histories (hypertension, 
diabetes, and dyslipidemia) were matched between the gallstone and control groups. The selection bias was min-
imized by sorting the control I participants using a random number order and then selecting them from top to 
bottom. It was presumed that the matched control I participants were involved at the same time as each matched 
gallstone participant (index date). Thus, participants in the control group who died before the index date were 
excluded. Participants who had a previous history of renal stones were excluded from both the gallstone and 
control groups. A total of 703 participants were excluded in the gallstone group. A total of 87 gallstone patients 
were additionally excluded due to the insufficient matching of participants. Finally, 20,711 gallstone patients and 
82,844 control I participants were included in this study (Fig. 1a).
Study II. Renal stone patients were matched 1:4 with the control II participants who were not diagnosed with 
renal stones from 2002 through 2013. The control group was extracted from the total population (n = 1,101,568). 
The matching factors were identical to those of study I (age, group, sex, income group, region of residence, and 
Characteristics
Gallstone
Crude P-value Adjusted† P-value
Age <30 years old, men (n = 10,480)
  Renal stone 1.78 (1.05–3.02) 0.032* 1.78 (1.05–3.02) 0.032*
  Control 1.00 1.00
Age <30 years old, women (n = 4,610)
  Renal stone 3.26 (1.72–6.18) <0.001* 3.27 (1.72–6.20) <0.001*
  Control 1.00 1.00
Age ≥30 and <60 years old, men (n = 53,690)
  Renal stone 1.85 (1.62–2.11) <0.001* 1.85 (1.62–2.11) <0.001*
  Control 1.00 1.00
Age ≥30 and <60 years old, women (n = 27,060)
  Renal stone 2.43 (2.03–2.91) <0.001* 2.43 (2.03–2.91) <0.001*
  Control 1.00 1.00
Age ≥60 years old, men (n = 12,130)
  Renal stone 1.62 (1.32–1.99) <0.001* 1.63 (1.32–2.00) <0.001*
  Control 1.00 1.00
Age ≥60 years old, women (n = 10,105)
  Renal stone 2.15 (1.72–2.69) <0.001* 2.15 (1.71–2.69) <0.001*
  Control 1.00 1.00
Table 5. Subgroup analysis of crude and adjusted hazard ratios (95% confidence intervals) of renal stone for 
gallstone according to age and sex in study II. *Cox proportional hazard regression model, significance at 
P < 0.05. †Adjusted model for age, sex, income, region of residence, hypertension, diabetes, and dyslipidemia.
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past medical histories [hypertension, diabetes, and dyslipidemia]). The matching procedures and exclusion cri-
teria were also identical to those of study I. A total of 473 participants were excluded in the renal stone group. An 
additional 35 renal stone patients were excluded due to insufficient matching of participants. Eventually, = 23,615 
renal stone patients and 94,460 control II participants were analyzed in study II (Fig. 1b).
Variables. Age was divided into 5-year intervals: 0–4, 5–9, 10–14, …, and 85+ years old. A total of 
18 age groups were classified. The income groups were composed with 41 classes (one health aid class, 20 
self-employment health insurance classes, and 20 employment health insurance classes). These groups were 
reconstituted to 11 classes (class 1 [lowest income]-11 [highest income]). The 16 regions of residence were clas-
sified according to administrative districts. These regions were recategorized into urban (Seoul, Busan, Daegu, 
Incheon, Gwangju, Daejeon, and Ulsan) and rural (Gyeonggi, Gangwon, Chungcheongbuk, Chungcheongnam, 
Jeollabuk, Jeollanam, Gyeongsangbuk, Gyeongsangnam, and Jeju).
The past medical histories were investigated based on ICD-10 codes. For the strict disease criteria, hyperten-
sion (I10 and I15), diabetes (E10-E14), and dyslipidemia (E78) were included if the participants had visited a 
hospital or clinical with that diagnosis ≥2 times.
statistical Analyses. The rates of general characteristics were compared between the gallstone and control 
groups (study I) and between the renal stone and control groups (study II) using the chi-square test.
In study I, the hazard ratio (HR) of gallstones (independent variable) for renal stones (dependent variable) was 
analyzed using a Cox proportional hazards model. In study II, the HR of renal stones (independent variable) for 
gallstones (dependent variable) was analyzed using another Cox proportional hazards model. For each analysis, 
crude (simple) and adjusted (age, sex, income, region of residence, hypertension, diabetes, and dyslipidemia) 
models were applied, and the 95% confidence intervals (CIs) were calculated.
For the subgroup analysis, the participants were divided according to age and sex (0–29 years old, 30–59 years 
old, 60+ years old; men, and women).
Two-tailed analyses were performed, and P values less than 0.05 were considered to designate significance. 
SPSS v. 21.0 (IBM, Armonk, NY, USA) was used for statistical analyses.
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